<html>
<head>PUBMED IDs for FAD104</head>
<body bgcolor='#C5F0F2'><h1>FAD104</h1><a href='https://pubmed.ncbi.nlm.nih.gov/25671570/'>Fad104, a positive regulator of adipocyte differentiation, suppresses invasion and metastasis of melanoma cells by inhibition of STAT3 activity.</a> January 14  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26948083/'>FAD104, a Regulator of Adipogenesis and Osteogenesis, Interacts with the C-Terminal Region of STAT3 and Represses Malignant Transformation of Melanoma Cells.</a> February 2  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/26948077/'>Diminution of signal transducer and activator of transcription 3 signaling inhibits vascular permeability and anaphylaxis.</a> June 16  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/26948076/'>A mild topical steroid leads to progressive anti-inflammatory effects in the skin of patients with moderate-to-severe atopic dermatitis.</a> June 16  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27541078/'>Two cases with de novo 3q26.31 microdeletion suggest a role for FNDC3B in human craniofacial development.</a> August 20  2016<br></body></html>
